SRp30c Is a Repressor of 3′ Splice Site Utilization

REFERENCES

• Black, D. L. 1995. Finding splice sites within a wilderness of RNA. RNA 1: 763–771.
   PubMedGoogle Scholar
• Blanchette, M., and B. Chabot. 1997. A highly stable duplex structure sequesters the 5′ splice site region of hnRNP A1 alternative exon 7B. RNA 3: 405–419.
   PubMed Web of Science ®Google Scholar
• Blanchette, M., and B. Chabot. 1999. Modulation of exon skipping by high-affinity hnRNP A1-binding sites and by intron elements that repress splice site utilization. EMBO J. 18: 1939–1952.
   PubMed Web of Science ®Google Scholar
• Bourgeois, C. F., M. Popielarz, G. Hildwein, and J. Stevenin. 1999. Identification of a bidirectional splicing enhancer: differential involvement of SR proteins in 5′ or 3′ splice site activation. Mol. Cell. Biol. 19: 7347–7356.
   PubMedGoogle Scholar
• Chabot, B. 1996. Directing alternative splicing: cast and scenarios. Trends Genet. 12: 472–478.
   PubMedGoogle Scholar
• Chabot, B. 1994. Synthesis and purification of RNA substrates, p. 1–29. In D. Hames, and S. Higgins (ed.), RNA processing, vol. 1. Oxford University Press, Oxford, United Kingdom.
   Google Scholar
• Chabot, B., M. Blanchette, I. Lapierre, and H. La Branche. 1997. An intron element modulating 5′ splice site selection in the hnRNP A1 pre-mRNA interacts with hnRNP A1. Mol. Cell. Biol. 17: 1776–1786.
   PubMedGoogle Scholar
• Chan, R. C., and D. L. Black. 1995. Conserved intron elements repress splicing of a neuron-specific c-src exon in vitro. Mol. Cell. Biol. 15: 6377-6385. (Erratum, 17: 2970, 1997.)
   PubMed Web of Science ®Google Scholar
• Chan, R. C., and D. L. Black. 1997. The polypyrimidine tract binding protein binds upstream of neural cell-specific c-src exon N1 to repress the splicing of the intron downstream. Mol. Cell. Biol. 17: 4667–4676.
   PubMedGoogle Scholar
• Chou, M. Y., J. G. Underwood, J. Nikolic, M. H. Luu, and D. L. Black. 2000. Multisite RNA binding and release of polypyrimidine tract binding protein during the regulation of c-src neural-specific splicing. Mol. Cell 5: 949–957.
   PubMed Web of Science ®Google Scholar
• Clouet d'Orval, B., Y. d'Aubenton Carafa, P. Sirand-Pugnet, M. Gallego, E. Brody, and J. Marie. 1991. RNA secondary structure repression of a muscle-specific exon in HeLa cell nuclear extracts. Science 252: 1823–1828.
   PubMedGoogle Scholar
• Côté, J., J. Beaudoin, R. Tacke, and B. Chabot. 1995. The U1 small nuclear ribonucleoprotein/5′ splice site interaction affects U2AF65 binding to the downstream 3′ splice site. J. Biol. Chem. 270: 4031–4036.
   PubMedGoogle Scholar
• Côté, J., and B. Chabot. 1997. Natural base-pairing interactions between 5′ splice site and branch site sequences affect mammalian 5′ splice site selection. RNA 3: 1248–1261.
   PubMedGoogle Scholar
• Côté, J., M. J. Simard, and B. Chabot. 1999. An element in the 5′ common exon of the NCAM alternative splicing unit interacts with SR proteins and modulates 5′ splice site selection. Nucleic Acids Res. 27: 2529–2537.
   PubMedGoogle Scholar
• Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11: 1475–1489.
   PubMed Web of Science ®Google Scholar
• Elrick, L. L., M. B. Humphrey, T. A. Cooper, and S. M. Berget. 1998. A short sequence within two purine-rich enhancers determines 5′ splice site specificity. Mol. Cell. Biol. 18: 343–352.
   PubMedGoogle Scholar
• Eperon, I. C., D. C. Ireland, R. A. Smith, A. Mayeda, and A. R. Krainer. 1993. Pathways for selection of 5′ splice sites by U1 snRNPs and SF2/ASF. EMBO J. 12: 3607–3617.
   PubMedGoogle Scholar
• Gallego, M. E., R. Gattoni, J. Stevenin, J. Marie, and A. Expert-Bezancon. 1997. The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the beta-tropomyosin alternative exon 6A. EMBO J. 16: 1772–1784.
   PubMed Web of Science ®Google Scholar
• Gontarek, R. R., M. T. McNally, and K. Beemon. 1993. Mutation of an RSV intronic element abolishes both U11/U12 snRNP binding and negative regulation of splicing. Genes Dev. 7: 1926–1936.
   PubMedGoogle Scholar
• Gooding, C., G. C. Roberts, G. Moreau, B. Nadal-Ginard, and C. W. Smith. 1994. Smooth muscle-specific switching of alpha-tropomyosin mutually exclusive exon selection by specific inhibition of the strong default exon. EMBO J. 13: 3861–3872.
   PubMedGoogle Scholar
• Gooding, C., G. C. Roberts, and C. W. Smith. 1998. Role of an inhibitory pyrimidine element and polypyrimidine tract binding protein in repression of a regulated alpha-tropomyosin exon. RNA 4: 85–100.
   PubMedGoogle Scholar
• Granadino, B., L. O. F. Penalva, M. R. Green, J. Valcárcel, and L. Sanchez. 1997. Distinct mechanisms of splicing regulation in vivo by the Drosophila protein Sex-lethal. Proc. Natl. Acad. Sci. USA 94: 7343–7348.
   PubMedGoogle Scholar
• Graveley, B. R. 2001. Alternative splicing: increasing diversity in the proteomic world. Trends Genet. 17: 100–107.
   PubMed Web of Science ®Google Scholar
• Graveley, B. R. 2000. Sorting out the complexity of SR protein functions. RNA 6: 1197–1211.
   PubMed Web of Science ®Google Scholar
• Hanamura, A., J. F. Caceres, A. Mayeda, B. R. Franza, Jr., and A. R. Krainer. 1998. Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors. RNA 4: 430–444.
   PubMed Web of Science ®Google Scholar
• Hibbert, C. S., R. R. Gontarek, and K. L. Beemon. 1999. The role of overlapping U1 and U11 5′ splice site sequences in a negative regulator of splicing. RNA 5: 333–343.
   PubMedGoogle Scholar
• Horabin, J. I., and P. Schedl. 1993. Regulated splicing of the Drosophila Sex-lethal male exon involves a blockage mechanism. Mol. Cell. Biol. 13: 1408–1414.
   PubMedGoogle Scholar
• Horabin, J. I., and P. Schedl. 1993. Sex-lethal autoregulation requires multiple cis-acting elements upstream and downstream of the male exon and appears to depend largely on controlling the use of the male exon 5′ splice site. Mol. Cell. Biol. 13: 7734–7746.
   PubMedGoogle Scholar
• Humphrey, M. B., J. Bryan, T. A. Cooper, and S. M. Berget. 1995. A 32-nucleotide exon-splicing enhancer regulates usage of competing 5′ splice sites in a differential internal exon. Mol. Cell. Biol. 15: 3979–3988.
   PubMedGoogle Scholar
• Hutton, M., C. L. Lendon, P. Rizzu, M. Baker, S. Froelich, H. Houlden, S. Pickering-Brown, S. Chakraverty, A. Isaacs, A. Grover, J. Hackett, J. Adamson, S. Lincoln, D. Dickson, P. Davies, R. C. Petersen, M. Stevens, E. de Graaff, E. Wauters, J. van Baren, M. Hillebrand, M. Joosse, J. M. Kwon, P. Nowotny, P. Heutink, et al. 1998. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393: 702–705.
   PubMed Web of Science ®Google Scholar
• International Human Genome Sequencing Consortium. 2001. Initial sequencing and analysis of the human genome. Nature 409: 860–921.
   PubMed Web of Science ®Google Scholar
• Kan, J. L., and M. R. Green. 1999. Pre-mRNA splicing of IgM exons M1 and M2 is directed by a juxtaposed splicing enhancer and inhibitor. Genes Dev. 13: 462–471.
   PubMedGoogle Scholar
• Kanopka, A., O. Mühlemann, and G. Aküsjarvi. 1996. Inhibition by SR proteins of splicing of a regulated adenovirus pre-mRNA. Nature 381: 535–538.
   PubMed Web of Science ®Google Scholar
• Kohtz, J. D., S. F. Jamison, C. L. Will, P. Zuo, R. Lührmann, M. A. Garcia-Blanco, and J. L. Manley. 1994. Protein-protein interactions and 5′-splice-site recognition in mammalian mRNA precursors. Nature 368: 119–124.
   PubMed Web of Science ®Google Scholar
• Lamontagne, B., A. Tremblay, and S. Abou Elela. 2000. The N-terminal domain that distinguishes yeast from bacterial RNase III contains a dimerization signal required for efficient double-stranded RNA cleavage. Mol. Cell. Biol. 20: 1104–1115.
   PubMedGoogle Scholar
• Lavigueur, A., H. La Branche, A. R. Kornblihtt, and B. Chabot. 1993. A splicing enhancer in the human fibronectin alternate ED1 exon interacts with SR proteins and stimulates U2 snRNP binding. Genes Dev. 7: 2405–2417.
   PubMed Web of Science ®Google Scholar
• Lin, C. H., and J. G. Patton. 1995. Regulation of alternative 3′ splice site selection by constitutive splicing factors. RNA 1: 234–245.
   PubMedGoogle Scholar
• Liu, H. X., M. Zhang, and A. R. Krainer. 1998. Identification of functional exonic splicing enhancer motifs recognized by individual SR proteins. Genes Dev. 12: 1998–2012.
   PubMed Web of Science ®Google Scholar
• Lopez, A. J. 1998. Alternative splicing of pre-mRNA: developmental consequences and mechanisms of regulation. Annu. Rev. Genet. 32: 279–305.
   PubMed Web of Science ®Google Scholar
• Lou, H., D. M. Helfman, R. F. Gagel, and S. M. Berget. 1999. Polypyrimidine tract-binding protein positively regulates inclusion of an alternative 3′-terminal exon. Mol. Cell. Biol. 19: 78–85.
   PubMedGoogle Scholar
• McNally, L. M., and M. T. McNally. 1998. An RNA splicing enhancer-like sequence is a component of a splicing inhibitor element from Rous sarcoma virus. Mol. Cell Biol. 18: 3103–3111.
   PubMedGoogle Scholar
• McNally, L. M., and M. T. McNally. 1996. SR protein splicing factors interact with the Rous sarcoma virus negative regulator of splicing element. J. Virol. 70: 1163–1172.
   PubMedGoogle Scholar
• Nayler, O., W. Stratling, J. P. Bourquin, I. Stagljar, L. Lindemann, H. Jasper, A. M. Hartmann, F. O. Fackelmayer, A. Ullrich, and S. Stamm. 1998. SAF-B protein couples transcription and pre-mRNA splicing to SAR/MAR elements. Nucleic Acids Res. 26: 3542–3549.
   PubMed Web of Science ®Google Scholar
• Paca, R. E., C. S. Hibbert, C. T. O'Sullivan, and K. L. Beemon. 2001. Retroviral splicing suppressor requires three nonconsensus uridines in a 5′ splice site-like sequence. J. Virol. 75: 7763–7768.
   PubMedGoogle Scholar
• Pagani, F., E. Buratti, C. Stuani, M. Romano, E. Zuccato, M. Niksic, L. Giglio, D. Faraguna, and F. E. Baralle. 2000. Splicing factors induce cystic fibrosis transmembrane regulator exon 9 skipping through a nonevolutionary conserved intronic element. J. Biol. Chem. 275: 21041–21047.
   PubMed Web of Science ®Google Scholar
• Perez, I., J. G. McAfee, and J. G. Patton. 1997. Multiple RRMs contribute to RNA binding specificity and affinity for polypyrimidine tract binding protein. Biochemistry 36: 11881–11890.
   PubMedGoogle Scholar
• Petersen-Mahrt, S. K., C. Estmer, C. Ohrmalm, D. A. Matthews, W. C. Russell, and G. Akusjarvi. 1999. The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation. EMBO J. 18: 1014–1024.
   PubMed Web of Science ®Google Scholar
• Philips, A. V., L. T. Timchenko, and T. A. Cooper. 1998. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 280: 737–741.
   PubMed Web of Science ®Google Scholar
• Savkur, R. S., A. V. Philips, and T. A. Cooper. 2001. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat. Genet. 29: 40–47.
   PubMed Web of Science ®Google Scholar
• Screaton, G. R., J. F. Cáceres, A. Mayeda, M. V. Bell, M. Plebanski, D. G. Jackson, J. I. Bell, and A. R. Krainer. 1995. Identification and characterization of three members of the human SR family of pre-mRNA splicing factors. EMBO J. 14: 4336–4349.
   PubMed Web of Science ®Google Scholar
• Selvakumar, M., and D. M. Helfman. 1999. Exonic splicing enhancers contribute to the use of both 3′ and 5′ splice site usage of rat beta-tropomyosin pre-mRNA. RNA 5: 378–394.
   PubMedGoogle Scholar
• Simard, M. J., and B. Chabot. 2000. Control of hnRNP A1 alternative splicing: an intron element represses use of the common 3′ splice site. Mol. Cell. Biol. 20: 7353–7362.
   PubMedGoogle Scholar
• Singh, R., J. Valcárcel, and M. R. Green. 1995. Distinct binding specificities and functions of higher eukaryotic polypyrimidine tract-binding proteins. Science 268: 1173–1176.
   PubMed Web of Science ®Google Scholar
• Southby, J., C. Gooding, and C. W. J. Smith. 1999. Polypyrimidine tract binding protein functions as a repressor to regulate alternative splicing of α-actinin mutually exclusive exons. Mol. Cell. Biol. 19: 2699–2711.
   PubMedGoogle Scholar
• Staknis, D., and R. Reed. 1994. SR proteins promote the first specific recognition of pre-mRNA and are present together with the U1 small nuclear ribonucleoprotein particle in a general splicing enhancer complex. Mol. Cell. Biol. 14: 7670–7682.
   PubMed Web of Science ®Google Scholar
• Stoss, O., M. Olbrich, A. M. Hartmann, H. Konig, J. Memmott, A. Andreadis, and S. Stamm. 2001. The STAR/GSG family protein rSLM-2 regulates the selection of alternative splice sites. J. Biol. Chem. 276: 8665–8673.
   PubMedGoogle Scholar
• Stoss, O., F. W. Schwaiger, T. A. Cooper, and S. Stamm. 1999. Alternative splicing determines the intracellular localization of the novel nuclear protein Nop30 and its interaction with the splicing factor SRp30c. J. Biol. Chem. 274: 10951–10962.
   PubMedGoogle Scholar
• Valcárcel, J., and F. Gebauer. 1997. Post-transcriptional regulation: the dawn of PTB. Curr. Biol. 7: R705–R708.
   PubMed Web of Science ®Google Scholar
• Valcárcel, J., R. Singh, P. D. Zamore, and M. R. Green. 1993. The protein Sex-lethal antagonizes the splicing factor U2AF to regulate alternative splicing of transformer pre-mRNA. Nature 362: 171–175.
   PubMed Web of Science ®Google Scholar
• Wagner, E. J., and M. A. Garcia-Blanco. 2001. Polypyrimidine tract binding protein antagonizes exon definition. Mol. Cell. Biol. 21: 3281–3288.
   PubMed Web of Science ®Google Scholar
• Wang, Z., H. M. Hoffmann, and P. J. Grabowski. 1995. Intrinsic U2AF binding is modulated by exon enhancer signals in parallel with changes in splicing activity. RNA 1: 21–35.
   PubMed Web of Science ®Google Scholar
• Yuan, Y., D. M. Li, and H. Sun. 1998. PIR1, a novel phosphatase that exhibits high affinity to RNA. ribonucleoprotein complexes. J. Biol. Chem. 273: 20347–20353.
   PubMedGoogle Scholar